Reactive oxygen species (ROS) exert various biological effects and contribute to signaling events during physiological and pathological processes. Enhanced levels of ROS are highly associated with different tumors, a Western lifestyle, and a nutritional regime. The supplementation of food with traditional antioxidants was shown to be protective against cancer in a number of studies both in vitro and in vivo. However, recent large-scale human trials in well-nourished populations did not confirm the beneficial role of antioxidants in cancer, whereas there is a well-established connection between longevity of several human populations and increased amount of antioxidants in their diets. Although our knowledge about ROS generators, ROS scavengers, and ROS signaling has improved, the knowledge about the direct link between nutrition, ROS levels, and cancer is limited. These limitations are partly due to lack of standardized reliable ROS measurement methods, easily usable biomarkers, knowledge of ROS action in cellular compartments, and individual genetic predispositions. The current review summarizes ROS formation due to nutrition with respect to macronutrients and antioxidant micronutrients in the context of cancer and discusses signaling mechanisms, used biomarkers, and its limitations along with large-scale human trials. Antioxid. Redox Signal. 19, 2157–2196.
AdamsCH, WerelyCJ, VictorTC, HoalEG, RossouwG, and van HeldenPD. Allele frequencies for glutathione S-transferase and N-acetyltransferase 2 differ in African population groups and may be associated with oesophageal cancer or tuberculosis incidence. Clin Chem Lab Med, 41: 600–605, 2003.
2.
AgudoA, CabreraL, AmianoP, ArdanazE, BarricarteA, BerenguerT, ChirlaqueMD, DorronsoroM, JakszynP, LarranagaN, MartinezC, NavarroC, QuirosJR, SanchezMJ, TormoMJ, and GonzalezCA. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain). Am J Clin Nutr, 85: 1634–1642, 2007.
3.
AguirreJ and LambethJD. Nox enzymes from fungus to fly to fish and what they tell us about Nox function in mammals. Free Radic Biol Med, 49: 1342–1353, 2010.
4.
AhmadKA, ClementMV, HanifIM, and PervaizS. Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution. Cancer Res, 64: 1452–1459, 2004.
5.
AhmadKA, ClementMV, and PervaizS. Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis. Ann N Y Acad Sci, 1010: 365–373, 2003.
6.
AklMR, AyoubNM, and SylvesterPW. Mechanisms mediating the synergistic anticancer effects of combined gamma-tocotrienol and sesamin treatment. Planta Med, 78: 1731–1739, 2012.
7.
AlabasterO, TangZ, FrostA, and ShivapurkarN. Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis, 16: 127–132, 1995.
8.
AlbanesD, HeinonenOP, HuttunenJK, TaylorPR, VirtamoJ, EdwardsBK, HaapakoskiJ, RautalahtiM, HartmanAM, and PalmgrenJ. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr, 62: 1427S–1430S, 1995.
9.
AlbrechtSC, BarataAG, GrosshansJ, TelemanAA, and DickTP. In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab, 14: 819–829, 2011.
10.
AljadaA, GhanimH, MohantyP, SyedT, BandyopadhyayA, and DandonaP. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr, 80: 51–57, 2004.
11.
AllenNE, ApplebyPN, RoddamAW, TjonnelandA, JohnsenNF, OvervadK, BoeingH, WeikertS, KaaksR, LinseisenJ, TrichopoulouA, MisirliG, TrichopoulosD, SacerdoteC, GrioniS, PalliD, TuminoR, Bueno-de-MesquitaHB, KiemeneyLA, BarricarteA, LarranagaN, SanchezMJ, AgudoA, TormoMJ, RodriguezL, StattinP, HallmansG, BinghamS, KhawKT, SlimaniN, RinaldiS, BoffettaP, RiboliE, KeyTJ, and European Prospective Investigation into Cancer and Nutrition. Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr, 88: 1567–1575, 2008.
12.
AmbrosoneCB, FreudenheimJL, ThompsonPA, BowmanE, VenaJE, MarshallJR, GrahamS, LaughlinR, NemotoT, and ShieldsPG. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res, 59: 602–606, 1999.
13.
AntonenkovVD, GrunauS, OhlmeierS, and HiltunenJK. Peroxisomes are oxidative organelles. Antioxid Redox Signal, 13: 525–537, 2010.
14.
AntunesF and CadenasE. Estimation of H2O2 gradients across biomembranes. FEBS Lett, 475: 121–126, 2000.
15.
Appenzeller-HerzogC. Glutathione- and non-glutathione-based oxidant control in the endoplasmic reticulum. J Cell Sci, 124: 847–855, 2011.
16.
Arsova-SarafinovskaZ, MatevskaN, EkenA, PetrovskiD, BanevS, DzikovaS, GeorgievV, SikoleA, ErdemO, SayalA, AydinA, and DimovskiAJ. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int Urol Nephrol, 41: 63–70, 2009.
17.
ArtsIC, JacobsDRJr., GrossM, HarnackLJ, and FolsomAR. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control, 13: 373–382, 2002.
18.
AtkinsonJ, EpandRF, and EpandRM. Tocopherols and tocotrienols in membranes: a critical review. Free Radic Biol Med, 44: 739–764, 2008.
19.
AwTY. Determinants of intestinal detoxication of lipid hydroperoxides. Free Radic Res, 28: 637–646, 1998.
20.
AzzamEI, de ToledoSM, and LittleJB. Stress signaling from irradiated to non-irradiated cells. Curr Cancer Drug Targets, 4: 53–64, 2004.
21.
BabiorBM. NADPH oxidase: an update. Blood, 93: 1464–1476, 1999.
22.
BadidN, AhmedFZ, MerzoukH, BelbraouetS, MokhtariN, MerzoukSA, BenhabibR, HamzaouiD, and NarceM. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res, 16: 159–167, 2010.
23.
BagiZ, KollerA, and KaleyG. PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes. Am J Physiol Heart Circ Physiol, 286: H742–H748, 2004.
24.
BanhegyiG, MandlJ, and CsalaM. Redox-based endoplasmic reticulum dysfunction in neurological diseases. J Neurochem, 107: 20–34, 2008.
25.
BanimPJ, LubenR, McTaggartA, WelchA, WarehamN, KhawKT, and HartAR. Dietary antioxidants and the aetiology of pancreatic cancer: a cohort study using data from food diaries and biomarkers. Gut, 2012 [Epub ahead of print]; DOI:10.1136/gutjnl-2011-301908.
26.
BanningA, FlorianS, DeubelS, ThalmannS, Muller-SchmehlK, JacobaschG, and Brigelius-FloheR. GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells. Antioxid Redox Signal, 10: 1491–1500, 2008.
27.
BarveA, KhorTO, NairS, ReuhlK, SuhN, ReddyB, NewmarkH, and KongAN. Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer, 124: 1693–1699, 2009.
28.
BasnetP and Skalko-BasnetN. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules, 16: 4567–4598, 2011.
29.
BehneD and KyriakopoulosA. Mammalian selenium-containing proteins. Annu Rev Nutr, 21: 453–473, 2001.
BenhamouS, LeeWJ, AlexandrieAK, BoffettaP, BouchardyC, ButkiewiczD, BrockmollerJ, ClapperML, DalyA, DolzanV, FordJ, GaspariL, HaugenA, HirvonenA, Husgafvel-PursiainenK, Ingelman-SundbergM, KalinaI, KiharaM, KremersP, Le MarchandL, LondonSJ, Nazar-StewartV, Onon-KiharaM, RannugA, RomkesM, RybergD, SeidegardJ, ShieldsP, StrangeRC, StuckerI, To-FiguerasJ, BrennanP, and TaioliE. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis, 23: 1343–1350, 2002.
32.
BenzieIF. Evolution of dietary antioxidants. Comp Biochem Physiol A Mol Integr Physiol, 136: 113–126, 2003.
33.
BertramJS and BortkiewiczH. Dietary carotenoids inhibit neoplastic transformation and modulate gene expression in mouse and human cells. Am J Clin Nutr, 62: 1327S–1336S, 1995.
34.
BhattacharjeeS, PennathurS, ByunJ, CrowleyJ, MuellerD, GischlerJ, HotchkissRS, and HeineckeJW. NADPH oxidase of neutrophils elevates o,o′-dityrosine cross-links in proteins and urine during inflammation. Arch Biochem Biophys, 395: 69–77, 2001.
35.
BienertGP, SchjoerringJK, and JahnTP. Membrane transport of hydrogen peroxide. Biochim Biophys Acta, 1758: 994–1003, 2006.
36.
BlockKI and MeadMN. Vitamin C in alternative cancer treatment: historical background. Integr Cancer Ther, 2: 147–154, 2003.
37.
BlokhinaO and FagerstedtKV. Oxidative metabolism, ROS and NO under oxygen deprivation. Plant Physiol Biochem, 48: 359–373, 2010.
38.
BobeG, PetersonJJ, GridleyG, HyerM, DwyerJT, and BrownLM. Flavonoid consumption and esophageal cancer among black and white men in the United States. Int J Cancer, 125: 1147–1154, 2009.
39.
BosettiC, PelucchiC, and La VecchiaC. Diet and cancer in Mediterranean countries: carbohydrates and fats. Public Health Nutr, 12: 1595–1600, 2009.
40.
BouR, CodonyR, TresA, DeckerEA, and GuardiolaF. Determination of hydroperoxides in foods and biological samples by the ferrous oxidation-xylenol orange method: a review of the factors that influence the method's performance. Anal Biochem, 377: 1–15, 2008.
41.
BramleyP, ElmadfaI, KafatosA, KellyF, ManiosY, RoxboroughH, SchuchW, SheehyP, and WagnerK. Vitamin E. J Sci Food Agric, 80: 913–938, 2000.
42.
BrandMD. The sites and topology of mitochondrial superoxide production. Exp Gerontol, 45: 466–472, 2010.
43.
Brigelius-FloheR. Selenium compounds and selenoproteins in cancer. Chem Biodivers, 5: 389–395, 2008.
44.
Brigelius-FloheR and KippAP. Physiological functions of GPx2 and its role in inflammation-triggered carcinogenesis. Ann N Y Acad Sci, 1259: 19–25, 2012.
45.
BrivibaK, BubA, MosenederJ, SchwerdtleT, HartwigA, KullingS, and WatzlB. No differences in DNA damage and antioxidant capacity between intervention groups of healthy, nonsmoking men receiving 2, 5, or 8 servings/day of vegetables and fruit. Nutr Cancer, 60: 164–170, 2008.
46.
BrockKE, KeL, GridleyG, ChiuBC, ErshowAG, LynchCF, GraubardBI, and CantorKP. Fruit, vegetables, fibre and micronutrients and risk of US renal cell carcinoma. Br J Nutr, 108: 1077–1085, 2012.
47.
BrownDI and GriendlingKK. Nox proteins in signal transduction. Free Radic Biol Med, 47: 1239–1253, 2009.
48.
BrownK, MorriceP, and DuthieG. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am J Clin Nutr, 60: 383–387, 1994.
49.
BuettnerGR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys, 300: 535–543, 1993.
50.
CabanillasF. Vitamin C and cancer: what can we conclude −1,609 patients and 33 years later?. P R Health Sci J, 29: 215–217, 2010.
51.
CaiC, ChingA, LagaceC, and LinsenmayerT. Nuclear ferritin-mediated protection of corneal epithelial cells from oxidative damage to DNA. Dev Dyn, 237: 2676–2683, 2008.
52.
CameronE and PaulingL. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A, 75: 4538–4542, 1978.
53.
CardosoAR, ChausseB, da CunhaFM, Luevano-MartinezLA, MarazziTB, PessoaPS, QueliconiBB, and KowaltowskiAJ. Mitochondrial compartmentalization of redox processes. Free Radic Biol Med, 52: 2201–2208, 2012.
54.
CarewJS and HuangP. Mitochondrial defects in cancer. Mol Cancer, 1: 9, 2002.
55.
CarlsenMH, HalvorsenBL, HolteK, BohnSK, DraglandS, SampsonL, WilleyC, SenooH, UmezonoY, SanadaC, BarikmoI, BerheN, WillettWC, PhillipsKM, JacobsDRJr., and BlomhoffR. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J, 9: 3, 2010.
56.
CarlsonBA, YooMH, TobeR, MuellerC, Naranjo-SuarezS, HoffmannVJ, GladyshevVN, and HatfieldDL. Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis, 33: 1806–1813, 2012.
57.
CarneroA. The PKB/AKT pathway in cancer. Curr Pharm Des, 16: 34–44, 2010.
58.
CarreroP, OkamotoK, CoumailleauP, O'BrienS, TanakaH, and PoellingerL. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol, 20: 402–415, 2000.
CerielloA and MotzE. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol, 24: 816–823, 2004.
61.
ChackoBK, ReilyC, SrivastavaA, JohnsonMS, YeY, UlasovaE, AgarwalA, ZinnKR, MurphyMP, KalyanaramanB, and Darley-UsmarV. Prevention of diabetic nephropathy in Ins2(+/)(−)(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem J, 432: 9–19, 2010.
62.
ChanDW, LiuVW, TsaoGS, YaoKM, FurukawaT, ChanKK, and NganHY. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis, 29: 1742–1750, 2008.
63.
ChenH and ShiH. A reducing environment stabilizes HIF-2alpha in SH-SY5Y cells under hypoxic conditions. FEBS Lett, 582: 3899–3902, 2008.
64.
ChenH and TappelAL. Protection of vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q0, coenzyme Q10, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo. Free Radic Biol Med, 18: 949–953, 1995.
65.
ChenN and Karantza-WadsworthV. Role and regulation of autophagy in cancer. Biochim Biophys Acta, 1793: 1516–1523, 2009.
66.
ChenY, AzadMB, and GibsonSB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ, 16: 1040–1052, 2009.
67.
CherubiniA, RuggieroC, PolidoriMC, and MecocciP. Potential markers of oxidative stress in stroke. Free Radic Biol Med, 39: 841–852, 2005.
68.
ChoKJ, SeoJM, and KimJH. Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species. Mol Cells, 32: 1–5, 2011.
69.
ClarkLC, CantorKP, and AllawayWH. Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health, 46: 37–42, 1991.
70.
ClarkLC, CombsGFJr., TurnbullBW, SlateEH, ChalkerDK, ChowJ, DavisLS, GloverRA, GrahamGF, GrossEG, KrongradA, LesherJLJr., ParkHK, SandersBBJr., SmithCL, and TaylorJR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276: 1957–1963, 1996.
71.
CochemeHM and MurphyMP. Can antioxidants be effective therapeutics?. Curr Opin Investig Drugs, 11: 426–431, 2010.
72.
CochemeHM, QuinC, McQuakerSJ, CabreiroF, LoganA, PrimeTA, AbakumovaI, PatelJV, FearnleyIM, JamesAM, PorteousCM, SmithRA, SaeedS, CarreJE, SingerM, GemsD, HartleyRC, PartridgeL, and MurphyMP. Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab, 13: 340–350, 2011.
73.
CombaA, LinYH, EynardAR, ValentichMA, Fernandez-ZapicoME, and PasqualiniME. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev, 30: 325–342, 2011.
74.
CookeMS, LoftS, OlinskiR, EvansMD, BialkowskiK, WagnerJR, DedonPC, MollerP, GreenbergMM, and CadetJ. Recommendations for standardized description of and nomenclature concerning oxidatively damaged nucleobases in DNA. Chem Res Toxicol, 23: 705–707, 2010.
75.
CotterchioM, BoucherBA, MannoM, GallingerS, OkeyA, and HarperP. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr, 136: 3046–3053, 2006.
76.
Dalle-DonneI, RossiR, ColomboR, GiustariniD, and MilzaniA. Biomarkers of oxidative damage in human disease. Clin Chem, 52: 601–623, 2006.
77.
DandonaP, MohantyP, HamoudaW, GhanimH, AljadaA, GargR, and KumarV. Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations. J Clin Endocrinol Metab, 86: 2899–2902, 2001.
78.
de HaanJB, BladierC, GriffithsP, KelnerM, O'SheaRD, CheungNS, BronsonRT, SilvestroMJ, WildS, ZhengSS, BeartPM, HertzogPJ, and KolaI. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J Biol Chem, 273: 22528–22536, 1998.
79.
DennertG, ZwahlenM, BrinkmanM, VincetiM, ZeegersMP, and HorneberM. Selenium for preventing cancer. Cochrane Database Syst Rev. CD005195, 2011.
80.
Di MascioP, MurphyME, and SiesH. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr, 53: 194S–200S, 1991.
81.
DickinsonBC and ChangCJ. A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J Am Chem Soc, 130: 9638–9639, 2008.
82.
DickinsonBC, SrikunD, and ChangCJ. Mitochondrial-targeted fluorescent probes for reactive oxygen species. Curr Opin Chem Biol, 14: 50–56, 2010.
83.
DieboldI, FlugelD, BechtS, BelaibaRS, BonelloS, HessJ, KietzmannT, and GorlachA. The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4. Antioxid Redox Signal, 13: 425–436, 2010.
84.
DimovaEY, MichielsC, and KietzmannT. Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets. Curr Pharm Des, 15: 3867–3877, 2009.
85.
DimovaEY, SamoylenkoA, and KietzmannT. Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid Redox Signal, 6: 777–791, 2004.
86.
Diwadkar-NavsariwalaV, PrinsGS, SwansonSM, BirchLA, RayVH, HedayatS, LantvitDL, and DiamondAM. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A, 103: 8179–8184, 2006.
87.
DizdarogluM, JarugaP, BirinciogluM, and RodriguezH. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med, 32: 1102–1115, 2002.
88.
DotanY, LichtenbergD, and PinchukI. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res, 43: 200–227, 2004.
89.
Druesne-PecolloN, Latino-MartelP, NoratT, BarrandonE, BertraisS, GalanP, and HercbergS. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer, 127: 172–184, 2010.
90.
Duffield-LillicoAJ, SlateEH, ReidME, TurnbullBW, WilkinsPA, CombsGFJr., ParkHK, GrossEG, GrahamGF, StrattonMS, MarshallJR, ClarkLC, and Nutritional Prevention of Cancer Study Group. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst, 95: 1477–1481, 2003.
91.
DuthieG and CrozierA. Plant-derived phenolic antioxidants. Curr Opin Clin Nutr Metab Care, 3: 447–451, 2000.
92.
EberhardtMV, LeeCY, and LiuRH. Antioxidant activity of fresh apples. Nature, 405: 903–904, 2000.
93.
EglerRA, FernandesE, RothermundK, SereikaS, de Souza-PintoN, JarugaP, DizdarogluM, and ProchownikEV. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene, 24: 8038–8050, 2005.
94.
FernandesAP and HolmgrenA. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal, 6: 63–74, 2004.
95.
FialaES, SohnOS, LiH, El-BayoumyK, and SodumRS. Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate. Carcinogenesis, 18: 1809–1815, 1997.
96.
FinkelT. Signal transduction by reactive oxygen species. J Cell Biol, 194: 7–15, 2011.
97.
Fisher-WellmanK and BloomerRJ. Macronutrient specific postprandial oxidative stress: relevance to the development of insulin resistance. Curr Diabetes Rev, 5: 228–238, 2009.
98.
FloegelA, KimD, ChungS, KooSI, and ChunOK. Comparison of ABTS/DPPH assays to measure antioxidant capacity in popular antioxidant-rich US foods. J Food Compos Anal, 24: 1043–1048, 2011.
99.
FortunoA, San JoseG, MorenoMU, BeloquiO, DiezJ, and ZalbaG. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes, 55: 209–215, 2006.
100.
FoyerCH and NoctorG. Ascorbate and glutathione: the heart of the redox hub. Plant Physiol, 155: 2–18, 2011.
101.
FragaCG, MotchnikPA, ShigenagaMK, HelbockHJ, JacobRA, and AmesBN. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A, 88: 11003–11006, 1991.
102.
FrancoR, SchoneveldO, GeorgakilasAG, and PanayiotidisMI. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett, 266: 6–11, 2008.
103.
FrankelEN, WaterhouseAL, and KinsellaJE. Inhibition of human LDL oxidation by resveratrol. Lancet, 341: 1103–1104, 1993.
104.
FrantzS, KellyRA, and BourcierT. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem, 276: 5197–5203, 2001.
105.
FrederiksWM and Vreeling-SindelarovaH. Ultrastructural localization of xanthine oxidoreductase activity in isolated rat liver cells. Acta Histochem, 104: 29–37, 2002.
106.
FuTY, HouYY, ChuST, LiuCF, HuangCH, ChenHC, HsiaoM, LuPJ, WangJS, and GerLP. Manganese superoxide dismutase and glutathione peroxidase as prognostic markers in patients with buccal mucosal squamous cell carcinomas. Head Neck, 33: 1606–1615, 2011.
107.
FukudaR, KellyB, and SemenzaGL. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res, 63: 2330–2334, 2003.
108.
FukumuraH, SatoM, KezukaK, SatoI, FengX, OkumuraS, FujitaT, YokoyamaU, EguchiH, IshikawaY, and SaitoT. Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells. J Physiol Sci, 62: 251–257, 2012.
109.
GaoN, JiangBH, LeonardSS, CorumL, ZhangZ, RobertsJR, AntoniniJ, ZhengJZ, FlynnDC, CastranovaV, and ShiX. p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J Biol Chem, 277: 45041–45048, 2002.
110.
GaoP, ZhangH, DinavahiR, LiF, XiangY, RamanV, BhujwallaZM, FelsherDW, ChengL, PevsnerJ, LeeLA, SemenzaGL, and DangCV. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell, 12: 230–238, 2007.
111.
Garcia-FuentesE, MurriM, Garrido-SanchezL, Garcia-SerranoS, Garcia-AlmeidaJM, Moreno-SantosI, TinahonesFJ, and Macias-GonzalezM. PPARgamma expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. Obesity, 18: 952–958, 2010.
112.
GeybelsMS, HutterCM, KwonEM, OstranderEA, FuR, FengZ, StanfordJL, and PetersU. Variation in selenoenzyme genes and prostate cancer risk and survival. Prostate, 2012 [Epub ahead of print]; DOI:10.1002/pros.22617.
113.
GilbertR, MetcalfeC, FraserWD, DonovanJ, HamdyF, NealDE, LaneJA, and MartinRM. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade. Cancer Causes Control, 23: 1865–1873, 2012.
114.
GiorgioM, MigliaccioE, OrsiniF, PaolucciD, MoroniM, ContursiC, PellicciaG, LuziL, MinucciS, MarcaccioM, PintonP, RizzutoR, BernardiP, PaolucciF, and PelicciPG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell, 122: 221–233, 2005.
115.
GladeMJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition, 15: 523–526, 1999.
116.
GoYM and JonesDP. Redox control systems in the nucleus: mechanisms and functions. Antioxid Redox Signal, 13: 489–509, 2010.
117.
GoYM, ZieglerTR, JohnsonJM, GuL, HansenJM, and JonesDP. Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells. Free Radic Biol Med, 42: 363–370, 2007.
118.
GoodmanGE, ThornquistMD, BalmesJ, CullenMR, MeyskensFLJr., OmennGS, ValanisB, and WilliamsJHJr.The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst, 96: 1743–1750, 2004.
119.
GoodmanM, BostickRM, KucukO, and JonesDP. Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic Biol Med, 51: 1068–1084, 2011.
120.
GorlachA, DieboldI, Schini-KerthVB, Berchner-PfannschmidtU, RothU, BrandesRP, KietzmannT, and BusseR. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ Res, 89: 47–54, 2001.
121.
GorlachA, KlappaP, and KietzmannT. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal, 8: 1391–1418, 2006.
122.
GrahamD, HuynhNN, HamiltonCA, BeattieE, SmithRA, CochemeHM, MurphyMP, and DominiczakAF. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension, 54: 322–328, 2009.
123.
GreenleeH, KwanML, KushiLH, SongJ, CastilloA, WeltzienE, QuesenberryCPJr., and CaanBJ. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer, 118: 2048–2058, 2012.
124.
GuptaSC, HeviaD, PatchvaS, ParkB, KohW, and AggarwalBB. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal, 16: 1295–1322, 2012.
125.
GutscherM, PauleauAL, MartyL, BrachT, WabnitzGH, SamstagY, MeyerAJ, and DickTP. Real-time imaging of the intracellular glutathione redox potential. Nat Methods, 5: 553–559, 2008.
126.
GutscherM, SobottaMC, WabnitzGH, BallikayaS, MeyerAJ, SamstagY, and DickTP. Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases. J Biol Chem, 284: 31532–31540, 2009.
127.
GutteridgeJM and HalliwellB. Antioxidants: molecules, medicines, and myths. Biochem Biophys Res Commun, 393: 561–564, 2010.
128.
GuzmanJN, Sanchez-PadillaJ, WokosinD, KondapalliJ, IlijicE, SchumackerPT, and SurmeierDJ. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature, 468: 696–700, 2010.
129.
HailNJr., ChenP, KepaJJ, BushmanLR, and ShearnC. Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis. Free Radic Biol Med, 49: 109–116, 2010.
130.
HalliwellB. Vitamin C and genomic stability. Mutat Res, 475: 29–35, 2001.
131.
HalliwellB. The antioxidant paradox. Lancet, 355: 1179–1180, 2000.
132.
HalliwellB. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev, 57: 104–113, 1999.
133.
HalliwellB, RafterJ, and JennerA. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not?. Am J Clin Nutr, 81: 268S–276S, 2005.
134.
HamAJ and LieblerDC. Vitamin E oxidation in rat liver mitochondria. Biochemistry, 34: 5754–5761, 1995.
135.
HamdySI, HiratsukaM, NaraharaK, EndoN, El-EnanyM, MoursiN, AhmedMS, and MizugakiM. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol, 55: 560–569, 2003.
136.
HanX, ShenT, and LouH. Dietary polyphenols and their biological significance. Int J Mol Sci, 2007: 8, 950–988.
137.
HansonGT, AggelerR, OglesbeeD, CannonM, CapaldiRA, TsienRY, and RemingtonSJ. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem, 279: 13044–13053, 2004.
138.
HaratsD, Ben-NaimM, DabachY, HollanderG, HaviviE, SteinO, and SteinY. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis, 85: 47–54, 1990.
139.
HardyM, ChalierF, OuariO, FinetJP, RockenbauerA, KalyanaramanB, and TordoP. Mito-DEPMPO synthesized from a novel NH2-reactive DEPMPO spin trap: a new and improved trap for the detection of superoxide. Chem Commun, 10: 1083–1085, 2007.
140.
HercbergS, GalanP, PreziosiP, BertraisS, MennenL, MalvyD, RousselAM, FavierA, and BrianconS. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med, 164: 2335–2342, 2004.
141.
HilemanEA, AchantaG, and HuangP. Superoxide dismutase: an emerging target for cancer therapeutics. Expert Opin Ther Targets, 5: 697–710, 2001.
142.
HilleR and NishinoT. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J, 9: 995–1003, 1995.
143.
HirvonenT, VirtamoJ, KorhonenP, AlbanesD, and PietinenP. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control, 12: 789–796, 2001.
144.
HodisHN, MackWJ, LaBreeL, MahrerPR, SevanianA, LiuCR, LiuCH, HwangJ, SelzerRH, AzenSP, and VEAPS Research Group. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation, 106: 1453–1459, 2002.
145.
HofferLJ, LevineM, AssoulineS, MelnychukD, PadayattySJ, RosadiukK, RousseauC, RobitailleL, and MillerWHJr.Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol, 19: 1969–1974, 2008.
146.
HogervorstJG, BaarsBJ, SchoutenLJ, KoningsEJ, GoldbohmRA, and van den BrandtPA. The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit Rev Toxicol, 40: 485–512, 2010.
147.
HollmanPC, CassidyA, ComteB, HeinonenM, RichelleM, RichlingE, SerafiniM, ScalbertA, SiesH, and VidryS. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr, 141: 989S–1009S, 2011.
148.
HolmgrenA, JohanssonC, BerndtC, LonnME, HudemannC, and LilligCH. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans, 33: 1375–1377, 2005.
149.
HopkinsMH, FedirkoV, JonesDP, TerryPD, and BostickRM. Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial. Cancer Epidemiol Biomarkers Prev, 19: 850–858, 2010.
150.
HuangD, OuB, and PriorRL. The chemistry behind antioxidant capacity assays. J Agric Food Chem, 53: 1841–1856, 2005.
151.
HuoYY, LiG, DuanRF, GouQ, FuCL, HuYC, SongBQ, YangZH, WuDC, and ZhouPK. PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts. Free Radic Biol Med, 44: 1578–1591, 2008.
152.
HurstR, HooperL, NoratT, LauR, AuneD, GreenwoodDC, VieiraR, CollingsR, HarveyLJ, SterneJA, BeynonR, SavovicJ, and Fairweather-TaitSJ. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr, 96: 111–122, 2012.
IchikawaM, NishinoT, NishinoT, and IchikawaA. Subcellular localization of xanthine oxidase in rat hepatocytes: high-resolution immunoelectron microscopic study combined with biochemical analysis. J Histochem Cytochem, 40: 1097–1103, 1992.
155.
ImaiH and NakagawaY. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med, 34: 145–169, 2003.
156.
ImlayJA. Pathways of oxidative damage. Annu Rev Microbiol, 57: 395–418, 2003.
157.
ImmenschuhS, Baumgart-VogtE, TanM, IwaharaS, RamadoriG, and FahimiHD. Differential cellular and subcellular localization of heme-binding protein 23/peroxiredoxin I and heme oxygenase-1 in rat liver. J Histochem Cytochem, 51: 1621–1631, 2003.
158.
InoueI, GotoS, MatsunagaT, NakajimaT, AwataT, HokariS, KomodaT, and KatayamaS. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism, 50: 3–11, 2001.
159.
ItoY, SuzukiS, YagyuK, SasakiR, SuzukiK, and AokiK. Relationship between serum carotenoid levels and cancer death rates in the residents, living in a rural area of Hokkaido, Japan. J Epidemiol, 7: 1–8, 1997.
160.
IwasakiM, InoueM, SasazukiS, MiuraT, SawadaN, YamajiT, ShimazuT, WillettWC, and TsuganeS. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Breast Cancer Res Treat, 124: 827–834, 2010.
161.
JablonskaE, GromadzinskaJ, SobalaW, ReszkaE, and WasowiczW. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr, 47: 47–54, 2008.
162.
JacobsEJ, ConnellCJ, ChaoA, McCulloughML, RodriguezC, ThunMJ, and CalleEE. Multivitamin use and colorectal cancer incidence in a US cohort: does timing matter?. Am J Epidemiol, 158: 621–628, 2003.
163.
JacobsEJ, HenionAK, BriggsPJ, ConnellCJ, McCulloughML, JonasCR, RodriguezC, CalleEE, and ThunMJ. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol, 156: 1002–1010, 2002.
164.
JamaluddinM, WangS, BoldoghI, TianB, and BrasierAR. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal, 19: 1419–1433, 2007.
165.
JamesAM, CochemeHM, SmithRA, and MurphyMP. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem, 280: 21295–21312, 2005.
166.
JangM and PezzutoJM. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett, 134: 81–89, 1998.
167.
JeonYJ, MyungSK, LeeEH, KimY, ChangYJ, JuW, ChoHJ, SeoHG, and HuhBY. Effects of beta-carotene supplements on cancer prevention: meta-analysis of randomized controlled trials. Nutr Cancer, 63: 1185–1195, 2011.
168.
JokilehtoT and JaakkolaPM. The role of HIF prolyl hydroxylases in tumour growth. J Cell Mol Med, 14: 758–770, 2010.
169.
JomovaK and ValkoM. Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des, 17: 3460–3473, 2011.
170.
KabatGC, KimMY, SartoGE, ShikanyJM, and RohanTE. Repeated measurements of serum carotenoid, retinol and tocopherol levels in relation to colorectal cancer risk in the Women's Health Initiative. Eur J Clin Nutr, 66: 549–554, 2012.
171.
KabatGC, KimMY, Wactawski-WendeJ, ShikanyJM, VitolinsMZ, and RohanTE. Intake of antioxidant nutrients and risk of non-Hodgkin's Lymphoma in the Women's Health Initiative. Nutr Cancer, 64: 245–254, 2012.
172.
KaikkonenJ, NyyssonenK, TomasiA, IannoneA, TuomainenTP, Porkkala-SaratahoE, and SalonenJT. Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and D-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study. Free Radic Res, 33: 329–340, 2000.
173.
KalyanaramanB, Darley-UsmarV, DaviesKJ, DenneryPA, FormanHJ, GrishamMB, MannGE, MooreK, RobertsLJ,2nd, and IschiropoulosH. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med, 52: 1–6, 2012.
174.
KamataH, ManabeT, OkaS, KamataK, and HirataH. Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett, 519: 231–237, 2002.
175.
KapahiP, BoultonME, and KirkwoodTB. Positive correlation between mammalian life span and cellular resistance to stress. Free Radic Biol Med, 26: 495–500, 1999.
176.
KarlsenA, SvendsenM, SeljeflotI, SommernesMA, SextonJ, BrevikA, ErlundI, SerafiniM, BastaniN, RembergSF, BorgeGI, CarlsenMH, BohnSK, MyhrstadMC, DragstedLO, DuttaroyAK, HaffnerK, LaakeP, DrevonCA, ArnesenH, CollinsA, TonstadS, and BlomhoffR. Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers. Br J Nutr, 106: 557–571, 2011.
177.
KarppiJ, KurlS, LaukkanenJA, and KauhanenJ. Serum beta-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study. Nutr Cancer, 64: 361–367, 2012.
178.
KasaiH, OkadaY, NishimuraS, RaoMS, and ReddyJK. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res, 49: 2603–2605, 1989.
179.
KazanietzMG. Targeting protein kinase C and “non-kinase” phorbol ester receptors: emerging concepts and therapeutic implications. Biochim Biophys Acta, 1754: 296–304, 2005.
180.
KietzmannT and GorlachA. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol, 16: 474–486, 2005.
181.
KietzmannT, JungermannK, and GorlachA. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thromb Haemost, 89: 666–673, 2003.
182.
KimJJ, ChaeSW, HurGC, ChoSJ, KimMK, ChoiJ, NamSY, KimWH, YangHK, and LeeBL. Manganese superoxide dismutase expression correlates with a poor prognosis in gastric cancer. Pathobiology, 70: 353–360, 2002.
183.
KirshVA, PetersU, MayneST, SubarAF, ChatterjeeN, JohnsonCC, HayesRB, and Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst, 99: 1200–1209, 2007.
184.
KiselevKV. Perspectives for production and application of resveratrol. Appl Microbiol Biotechnol, 90: 417–425, 2011.
185.
KnebelA, RahmsdorfHJ, UllrichA, and HerrlichP. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J, 15: 5314–5325, 1996.
186.
KobliakovVA. Mechanisms of tumor promotion by reactive oxygen species. Biochemistry (Mosc), 75: 675–685, 2010.
187.
KoideY, UranoY, KenmokuS, KojimaH, and NaganoT. Design and synthesis of fluorescent probes for selective detection of highly reactive oxygen species in mitochondria of living cells. J Am Chem Soc, 129: 10324–10325, 2007.
188.
KomiyaY, TsukinoH, NakaoH, KurodaY, ImaiH, and KatohT. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol, 131: 238–242, 2005.
189.
KongQ, BeelJA, and LilleheiKO. A threshold concept for cancer therapy. Med Hypotheses, 55: 29–35, 2000.
190.
KonishiH, TanakaM, TakemuraY, MatsuzakiH, OnoY, KikkawaU, and NishizukaY. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci U S A, 94: 11233–11237, 1997.
191.
KrinskyNI. The antioxidant and biological properties of the carotenoids. Ann N Y Acad Sci, 854: 443–447, 1998.
192.
KristalAR, ArnoldKB, NeuhouserML, GoodmanP, PlatzEA, AlbanesD, and ThompsonIM. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol, 172: 566–577, 2010.
193.
KryukovGV, CastellanoS, NovoselovSV, LobanovAV, ZehtabO, GuigoR, and GladyshevVN. Characterization of mammalian selenoproteomes. Science, 300: 1439–1443, 2003.
194.
KunduJK and SurhYJ. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett, 269: 243–261, 2008.
195.
KurzT, EatonJW, and BrunkUT. Redox activity within the lysosomal compartment: implications for aging and apoptosis. Antioxid Redox Signal, 13: 511–523, 2010.
196.
LanderHM, HajjarDP, HempsteadBL, MirzaUA, ChaitBT, CampbellS, and QuilliamLA. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem, 272: 4323–4326, 1997.
197.
LauthM. RAS and Hedgehog—partners in crime. Front Biosci, 17: 2259–2270, 2011.
198.
LavrovskyY, ChatterjeeB, ClarkRA, and RoyAK. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol, 35: 521–532, 2000.
199.
LeeJ, GiordanoS, and ZhangJ. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J, 441: 523–540, 2012.
200.
LeeSR, YangKS, KwonJ, LeeC, JeongW, and RheeSG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem, 277: 20336–20342, 2002.
201.
LeibovitzB, HuML, and TappelAL. Dietary supplements of vitamin E, beta-carotene, coenzyme Q10 and selenium protect tissues against lipid peroxidation in rat tissue slices. J Nutr, 120: 97–104, 1990.
202.
LeviF, PascheC, LucchiniF, GhidoniR, FerraroniM, and La VecchiaC. Resveratrol and breast cancer risk. Eur J Cancer Prev, 14: 139–142, 2005.
203.
LiH, KantoffPW, GiovannucciE, LeitzmannMF, GazianoJM, StampferMJ, and MaJ. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res, 65: 2498–2504, 2005.
204.
LiH, StampferMJ, GiovannucciEL, MorrisJS, WillettWC, GazianoJM, and MaJ. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst, 96: 696–703, 2004.
205.
LiehrJG. Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethylstilbestrol. Am J Clin Nutr, 54: 1256S–1260S, 1991.
206.
LievreA, ChapusotC, BouvierAM, ZinzindohoueF, PiardF, RoignotP, ArnouldL, BeauneP, FaivreJ, and Laurent-PuigP. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol, 23: 3517–3525, 2005.
207.
LimS, RashidMA, JangM, KimY, WonH, LeeJ, WooJT, KimYS, MurphyMP, AliL, HaJ, and KimSS. Mitochondria-targeted antioxidants protect pancreatic beta-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity. Cell Physiol Biochem, 28: 873–886, 2011.
208.
LinH, LuJP, LaflammeP, QiaoS, ShayeganB, BryskinI, MonardoL, WilsonBC, SinghG, and PinthusJH. Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies. Int J Oncol, 37: 761–766, 2010.
209.
LinJ, ZhangSM, WuK, WillettWC, FuchsCS, and GiovannucciE. Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol, 164: 644–651, 2006.
210.
LinseisenJ, WolframG, and MillerAB. Plasma 7beta-hydroxycholesterol as a possible predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev, 11: 1630–1637, 2002.
211.
LippmanSM, KleinEA, GoodmanPJ, LuciaMS, ThompsonIM, FordLG, ParnesHL, MinasianLM, GazianoJM, HartlineJA, ParsonsJK, BeardenJD, CrawfordED, GoodmanGE, ClaudioJ, WinquistE, CookED, KarpDD, WaltherP, LieberMM, KristalAR, DarkeAK, ArnoldKB, GanzPA, SantellaRM, AlbanesD, TaylorPR, ProbstfieldJL, JagpalTJ, CrowleyJJ, MeyskensFL, BakerLH, and ColtmanCA. Effect of selenium and vitamin E on risk of prostate cancer and other cancers. JAMA, 301: 39–51, 2009.
212.
LiuQ, Berchner-PfannschmidtU, MollerU, BrechtM, WotzlawC, AckerH, JungermannK, and KietzmannT. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc Natl Acad Sci U S A, 101: 4302–4307, 2004.
213.
LiuRH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr, 134: 3479S–3485S, 2004.
214.
LiuVW, ShiHH, CheungAN, ChiuPM, LeungTW, NagleyP, WongLC, and NganHY. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res, 61: 5998–6001, 2001.
215.
LongLH, LanAN, HsuanFT, and HalliwellB. Generation of hydrogen peroxide by “antioxidant” beverages and the effect of milk addition. Is cocoa the best beverage?. Free Radic Res, 31: 67–71, 1999.
216.
Lopez-TorresM and BarjaG. Lowered methionine ingestion as responsible for the decrease in rodent mitochondrial oxidative stress in protein and dietary restriction possible implications for humans. Biochim Biophys Acta, 1780: 1337–1347, 2008.
217.
LuC, ZhangD, WhitemanM, and ArmstrongJS. Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA?. Antioxid Redox Signal, 10: 651–660, 2008.
218.
LuanpitpongS, TalbottSJ, RojanasakulY, NimmannitU, PongrakhananonV, WangL, and ChanvorachoteP. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem, 285: 38832–38840, 2010.
219.
LubosE, LoscalzoJ, and HandyDE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal, 15: 1957–1997, 2011.
220.
LutsenkoEA, CarcamoJM, and GoldeDW. Vitamin C prevents DNA mutation induced by oxidative stress. J Biol Chem, 277: 16895–16899, 2002.
221.
MaffeiF, AngeloniC, MalagutiM, MoragaJM, PasquiF, PoliC, ColecchiaA, FestiD, HreliaP, and HreliaS. Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk. Mutat Res, 714: 88–92, 2011.
222.
MarkSD, QiaoYL, DawseySM, WuYP, KatkiH, GunterEW, FraumeniJFJr., BlotWJ, DongZW, and TaylorPR. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst, 92: 1753–1763, 2000.
223.
MarraM, SordelliIM, LombardiA, LambertiM, TarantinoL, GiudiceA, StiusoP, AbbruzzeseA, SperlonganoR, AccardoM, AgrestiM, CaragliaM, and SperlonganoP. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J Transl Med, 9: 171, 2011.
224.
MartinezJ and MorenoJJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol, 59: 865–870, 2000.
225.
MassaroM, HabibA, LubranoL, Del TurcoS, LazzeriniG, BourcierT, WekslerBB, and De CaterinaR. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A, 103: 15184–15189, 2006.
226.
MatesJM, SeguraJA, AlonsoFJ, and MarquezJ. Oxidative stress in apoptosis and cancer: an update. Arch Toxicol, 86: 1649–1665, 2012.
227.
MatsuiA, IkedaT, EnomotoK, HosodaK, NakashimaH, OmaeK, WatanabeM, HibiT, and KitajimaM. Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett, 151: 87–95, 2000.
228.
MatthewsJR, KaszubskaW, TurcattiG, WellsTN, and HayRT. Role of cysteine62 in DNA recognition by the p50 subunit of NF-kappa B. Nucleic Acids Res, 21: 1727–1734, 1993.
229.
MayneST, HandelmanGJ, and BeecherG. Beta-Carotene and lung cancer promotion in heavy smokers—a plausible relationship?. J Natl Cancer Inst, 88: 1513–1515, 1996.
230.
MayoJC, TanDX, SainzRM, Lopez-BurilloS, and ReiterRJ. Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants. Free Radic Res, 37: 543–553, 2003.
McCallMR and FreiB. Can antioxidant vitamins materially reduce oxidative damage in humans?. Free Radic Biol Med, 26: 1034–1053, 1999.
233.
McCubreyJA, SteelmanLS, ChappellWH, AbramsSL, WongEW, ChangF, LehmannB, TerrianDM, MilellaM, TafuriA, StivalaF, LibraM, BaseckeJ, EvangelistiC, MartelliAM, and FranklinRA. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta, 1773: 1263–1284, 2007.
234.
McEligotAJ, YangS, and MeyskensFLJr.Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Annu Rev Nutr, 25: 261–295, 2005.
235.
McGregorGP and BiesalskiHK. Rationale and impact of vitamin C in clinical nutrition. Curr Opin Clin Nutr Metab Care, 9: 697–703, 2006.
236.
MehdiMZ, AzarZM, and SrivastavaAK. Role of receptor and nonreceptor protein tyrosine kinases in H2O2-induced PKB and ERK1/2 signaling. Cell Biochem Biophys, 47: 1–10, 2007.
MeyerAS and FrankelEN. Antioxidant activity of hydroxycinnamic acids on human low-density lipoprotein oxidation. Methods Enzymol, 335: 256–265, 2001.
239.
MillerER3rd, Pastor-BarriusoR, DalalD, RiemersmaRA, AppelLJ, and GuallarE. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med, 142: 37–46, 2005.
240.
MillerEW, TulyathanO, IsacoffEY, and ChangCJ. Molecular imaging of hydrogen peroxide produced for cell signaling. Nat Chem Biol, 3: 263–267, 2007.
241.
MishinaNM, Tyurin-KuzminPA, MarkvichevaKN, VorotnikovAV, TkachukVA, LaketaV, SchultzC, LukyanovS, and BelousovVV. Does cellular hydrogen peroxide diffuse or act locally?. Antioxid Redox Signal, 14: 1–7, 2011.
242.
MitsuishiY, TaguchiK, KawataniY, ShibataT, NukiwaT, AburataniH, YamamotoM, and MotohashiH. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell, 22: 66–79, 2012.
243.
MiyagiS, IwamaN, KawabataT, and HasegawaK. Longevity and diet in Okinawa, Japan: the past, present and future. Asia Pac J Public Health, 15 Suppl: S3–S9, 2003.
244.
Modica-NapolitanoJS, KulawiecM, and SinghKK. Mitochondria and human cancer. Curr Mol Med, 7: 121–131, 2007.
245.
MohantyP, GhanimH, HamoudaW, AljadaA, GargR, and DandonaP. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr, 75: 767–772, 2002.
246.
MohantyP, HamoudaW, GargR, AljadaA, GhanimH, and DandonaP. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab, 85: 2970–2973, 2000.
247.
MolMJTM, de RijkeYB, DemackerPNM, and StalenhoefAFH. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis, 129: 169–176, 1997.
MorganMJ and LiuZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res, 21: 103–115, 2011.
250.
MorrowJD. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev, 32: 377–385, 2000.
251.
MuellerMJ. Archetype signals in plants: the phytoprostanes. Curr Opin Plant Biol, 7: 441–448, 2004.
252.
MuqbilI, BeckFW, BaoB, SarkarFH, MohammadRM, HadiSM, and AzmiAS. Old Wine in a New Bottle: the Warburg effect and anticancer mechanisms of resveratrol. Curr Pharm Des, 18: 1645–1654, 2012.
253.
MurphyMP. How mitochondria produce reactive oxygen species. Biochem J, 417: 1–13, 2009.
254.
MurphyMP, HolmgrenA, LarssonNG, HalliwellB, ChangCJ, KalyanaramanB, RheeSG, ThornalleyPJ, PartridgeL, GemsD, NystromT, BelousovV, SchumackerPT, and WinterbournCC. Unraveling the biological roles of reactive oxygen species. Cell Metab, 13: 361–366, 2011.
255.
MyungSK, KimY, JuW, ChoiHJ, and BaeWK. Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials. Ann Oncol, 21: 166–179, 2010.
256.
NarisawaT, FukauraY, HasebeM, ItoM, AizawaR, MurakoshiM, UemuraS, KhachikF, and NishinoH. Inhibitory effects of natural carotenoids, alpha-carotene, beta-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett, 107: 137–142, 1996.
257.
NarisawaT, FukauraY, HasebeM, NomuraS, OshimaS, SakamotoH, InakumaT, IshiguroY, TakayasuJ, and NishinoH. Prevention of N-methylnitrosourea-induced colon carcinogenesis in F344 rats by lycopene and tomato juice rich in lycopene. Jpn J Cancer Res, 89: 1003–1008, 1998.
258.
NathRG and ChungFL. Detection of exocyclic 1,N2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc Natl Acad Sci U S A, 91: 7491–7495, 1994.
259.
NavarroJ, ObradorE, CarreteroJ, PetschenI, AvinoJ, PerezP, and EstrelaJM. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med, 26: 410–418, 1999.
260.
NdiayeM, KumarR, and AhmadN. Resveratrol in cancer management: where are we and where we go from here?. Ann N Y Acad Sci, 1215: 144–149, 2011.
261.
NegisY, ZinggJM, LibinakiR, MeydaniM, and AzziA. Vitamin E and cancer. Nutr Cancer, 61: 875–878, 2009.
262.
NiethammerP, GrabherC, LookAT, and MitchisonTJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature, 459: 996–999, 2009.
263.
NishikawaT, EdelsteinD, DuXL, YamagishiS, MatsumuraT, KanedaY, YorekMA, BeebeD, OatesPJ, HammesHP, GiardinoI, and BrownleeM. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404: 787–790, 2000.
264.
NishinoH, MurakoshiM, TokudaH, and SatomiY. Cancer prevention by carotenoids. Arch Biochem Biophys, 483: 165–168, 2009.
265.
NohlH and GilleL. The bifunctional activity of ubiquinone in lysosomal membranes. Biogerontology, 3: 125–131, 2002.
266.
NomuraK, ImaiH, KoumuraT, KobayashiT, and NakagawaY. Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis. Biochem J, 351: 183–193, 2000.
267.
OberleyTD, VerwiebeE, ZhongW, KangSW, and RheeSG. Localization of the thioredoxin system in normal rat kidney. Free Radic Biol Med, 30: 412–424, 2001.
268.
OffordE, van PoppelG, and TyrrellR. Markers of oxidative damage and antioxidant protection: current status and relevance to disease. Free Radic Res, 33 Suppl: S5–S19, 2000.
269.
O'KeefeJH, GheewalaNM, and O'KeefeJO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol, 51: 249–255, 2008.
270.
OlsonSH, CarlsonMD, OstrerH, HarlapS, StoneA, WintersM, and AmbrosoneCB. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol Oncol, 93: 615–620, 2004.
271.
OrhanH, CoolenS, and MeermanJH. Quantification of urinary o,o′-dityrosine, a biomarker for oxidative damage to proteins, by high performance liquid chromatography with triple quadrupole tandem mass spectrometry. A comparison with ion-trap tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 827: 104–108, 2005.
272.
OstergaardH, HenriksenA, HansenFG, and WintherJR. Shedding light on disulfide bond formation: engineering a redox switch in green fluorescent protein. EMBO J, 20: 5853–5862, 2001.
273.
OstmanA, FrijhoffJ, SandinA, and BohmerFD. Regulation of protein tyrosine phosphatases by reversible oxidation. J Biochem, 150: 345–356, 2011.
274.
OzbenT. Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci, 96: 2181–2196, 2007.
275.
Palafox-CarlosH, Ayala-ZavalaJF, and Gonzalez-AguilarGA. The role of dietary fiber in the bioaccessibility and bioavailability of fruit and vegetable antioxidants. J Food Sci, 76: R6–R15, 2011.
276.
PatelD, ShuklaS, and GuptaS. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol, 30: 233–245, 2007.
277.
PelicanoH, CarneyD, and HuangP. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat, 7: 97–110, 2004.
278.
PerssonC, SasazukiS, InoueM, KurahashiN, IwasakiM, MiuraT, YeW, TsuganeS, and JPHC Study Group. Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study. Carcinogenesis, 29: 1042–1048, 2008.
279.
PetersU, FosterCB, ChatterjeeN, SchatzkinA, RedingD, AndrioleGL, CrawfordED, SturupS, ChanockSJ, and HayesRB. Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr, 85: 209–217, 2007.
280.
PetratF, de GrootH, and RauenU. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J, 356: 61–69, 2001.
281.
PetryA, WeitnauerM, and GorlachA. Receptor activation of NADPH oxidases. Antioxid Redox Signal, 13: 467–487, 2010.
282.
Pineda-MolinaE, KlattP, VazquezJ, MarinaA, Garcia de LacobaM, Perez-SalaD, and LamasS. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry, 40: 14134–14142, 2001.
283.
PriemeH, LoftS, NyyssonenK, SalonenJT, and PoulsenHE. No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion in smokers. Am J Clin Nutr, 65: 503–507, 1997.
284.
PrimeTA, ForkinkM, LoganA, FinichiuPG, McLachlanJ, Li PunPB, KoopmanWJ, LarsenL, LatterMJ, SmithRA, and MurphyMP. A ratiometric fluorescent probe for assessing mitochondrial phospholipid peroxidation within living cells. Free Radic Biol Med, 53: 544–553, 2012.
285.
PrutzWA, ButlerJ, and LandEJ. Interaction of copper(I) with nucleic acids. Int J Radiat Biol, 58: 215–234, 1990.
286.
QiaoYL, DawseySM, KamangarF, FanJH, AbnetCC, SunXD, JohnsonLL, GailMH, DongZW, YuB, MarkSD, and TaylorPR. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst, 101: 507–518, 2009.
287.
RajL, IdeT, GurkarAU, FoleyM, SchenoneM, LiX, TollidayNJ, GolubTR, CarrSA, ShamjiAF, SternAM, MandinovaA, SchreiberSL, and LeeSW. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature, 475: 231–234, 2011.
288.
RajneeshCP, ManimaranA, SasikalaKR, and AdaikappanP. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J, 49: 640–643, 2008.
289.
RamanM, ChenW, and CobbMH. Differential regulation and properties of MAPKs. Oncogene, 26: 3100–3112, 2007.
290.
RamseyMR and SharplessNE. ROS as a tumour suppressor?. Nat Cell Biol, 8: 1213–1215, 2006.
291.
RaoAV and SnyderDM. Raspberries and human health: a review. J Agric Food Chem, 58: 3871–3883, 2010.
292.
RaoMS and ReddyJK. Hepatocarcinogenesis of peroxisome proliferators. Ann N Y Acad Sci, 804: 573–587, 1996.
293.
RautalahtiMT, VirtamoJR, TaylorPR, HeinonenOP, AlbanesD, HaukkaJK, EdwardsBK, KarkkainenPA, Stolzenberg-SolomonRZ, and HuttunenJ. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer, 86: 37–42, 1999.
294.
RayPD, HuangBW, and TsujiY. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal, 24: 981–990, 2012.
295.
RaymanMP. Selenium and human health. Lancet, 379: 1256–1268, 2012.
296.
RehmanA, CollisCS, YangM, KellyM, DiplockAT, HalliwellB, and Rice-EvansC. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun, 246: 293–298, 1998.
297.
ReidME, Duffield-LillicoAJ, SlateE, NatarajanN, TurnbullB, JacobsE, CombsGFJr., AlbertsDS, ClarkLC, and MarshallJR. The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutr Cancer, 60: 155–163, 2008.
298.
ReisA, DominguesMR, OliveiraMM, and DominguesP. Identification of free radicals by spin trapping with DEPMPO and MCPIO using tandem mass spectrometry. Eur J Mass Spectrom, 15: 689–703, 2009.
299.
ReiterE, AzziA, and ZinggJM. Enhanced anti-proliferative effects of combinatorial treatment of delta-tocopherol and resveratrol in human HMC-1 cells. Biofactors, 30: 67–77, 2007.
300.
RheeSG, ChangTS, JeongW, and KangD. Methods for detection and measurement of hydrogen peroxide inside and outside of cells. Mol Cells, 29: 539–549, 2010.
301.
RichardD, KefiK, BarbeU, BauseroP, and VisioliF. Polyunsaturated fatty acids as antioxidants. Pharmacol Res, 57: 451–455, 2008.
302.
RichardDE, BerraE, and PouyssegurJ. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem, 275: 26765–26771, 2000.
303.
RichieJPJr., LeutzingerY, ParthasarathyS, MalloyV, OrentreichN, and ZimmermanJA. Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J, 8: 1302–1307, 1994.
304.
RiemerJ, BulleidN, and HerrmannJM. Disulfide formation in the ER and mitochondria: two solutions to a common process. Science, 324: 1284–1287, 2009.
305.
RobertsLJ and MorrowJD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med, 28: 505–513, 2000.
306.
Rodriguez-CuencaS, CochemeHM, LoganA, AbakumovaI, PrimeTA, RoseC, Vidal-PuigA, SmithAC, RubinszteinDC, FearnleyIM, JonesBA, PopeS, HealesSJ, LamBY, NeogiSG, McFarlaneI, JamesAM, SmithRA, and MurphyMP. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med, 48: 161–172, 2010.
307.
RossiM, BosettiC, NegriE, LagiouP, and La VecchiaC. Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr Cancer, 62: 871–877, 2010.
308.
RossiR, MilzaniA, Dalle-DonneI, GiustariniD, LusiniL, ColomboR, and Di SimplicioP. Blood glutathione disulfide: in vivo factor or in vitro artifact?. Clin Chem, 48: 742–753, 2002.
309.
RossnerPJr., GammonMD, TerryMB, AgrawalM, ZhangFF, TeitelbaumSL, EngSM, GaudetMM, NeugutAI, and SantellaRM. Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 15: 639–644, 2006.
310.
SalonenJT, NyyssonenK, SalonenR, LakkaHM, KaikkonenJ, Porkkala-SaratahoE, VoutilainenS, LakkaTA, RissanenT, LeskinenL, TuomainenTP, ValkonenVP, RistonmaaU, and PoulsenHE. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med, 248: 377–386, 2000.
311.
SanoT, UmedaF, HashimotoT, NawataH, and UtsumiH. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia, 41: 1355–1360, 1998.
312.
SatiaJA, LittmanA, SlatoreCG, GalankoJA, and WhiteE. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol, 169: 815–828, 2009.
313.
ScalbertA and WilliamsonG. Dietary intake and bioavailability of polyphenols. J Nutr, 130: 2073S–2085S, 2000.
314.
ScapagniniG, VastoS, AbrahamNG, CarusoC, ZellaD, and FabioG. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol, 44: 192–201, 2011.
315.
SchaferZT, GrassianAR, SongL, JiangZ, Gerhart-HinesZ, IrieHY, GaoS, PuigserverP, and BruggeJS. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature, 461: 109–113, 2009.
316.
Scherz-ShouvalR, ShvetsE, FassE, ShorerH, GilL, and ElazarZ. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J, 26: 1749–1760, 2007.
317.
SchlachtermanA, ValleF, WallKM, AziosNG, CastilloL, MorellL, WashingtonAV, CubanoLA, and DharmawardhaneSF. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol, 1: 19–27, 2008.
318.
SchraderM and FahimiHD. Peroxisomes and oxidative stress. Biochim Biophys Acta, 1763: 1755–1766, 2006.
319.
SchwarzlanderM, LoganDC, FrickerMD, and SweetloveLJ. The circularly permuted yellow fluorescent protein cpYFP that has been used as a superoxide probe is highly responsive to pH but not superoxide in mitochondria: implications for the existence of superoxide ‘flashes'. Biochem J, 437: 381–387, 2011.
320.
SeetRC, LeeCY, ChanBP, SharmaVK, TeohHL, VenketasubramanianN, LimEC, ChongWL, LooiWF, HuangSH, OngBK, and HalliwellB. Oxidative damage in ischemic stroke revealed using multiple biomarkers. Stroke, 42: 2326–2329, 2011.
321.
SeilerA, SchneiderM, ForsterH, RothS, WirthEK, CulmseeC, PlesnilaN, KremmerE, RadmarkO, WurstW, BornkammGW, SchweizerU, and ConradM. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab, 8: 237–248, 2008.
322.
SekiguchiM and TsuzukiT. Oxidative nucleotide damage: consequences and prevention. Oncogene, 21: 8895–8904, 2002.
323.
SenerDE, GonencA, AkinciM, and TorunM. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem Funct, 25: 377–382, 2007.
324.
SeoMS, KangSW, KimK, BainesIC, LeeTH, and RheeSG. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem, 275: 20346–20354, 2000.
325.
Serafini M and Del RioD. Understanding the association between dietary antioxidants, redox status and disease: is the total antioxidant capacity the right tool?. Redox Rep, 9: 145–152, 2004.
326.
SerafiniM, JakszynP, Lujan-BarrosoL, AgudoA, Bas Bueno-de-MesquitaH, van DuijnhovenFJ, JenabM, NavarroC, PalliD, BoeingH, WallstromP, RegnerS, NumansME, CarneiroF, Boutron-RuaultMC, Clavel-ChapelonF, MoroisS, GrioniS, PanicoS, TuminoR, SacerdoteC, Ramon QuirosJ, Molina-MontesE, Huerta CastanoJM, BarricarteA, AmianoP, KhawKT, WarehamN, AllenNE, KeyTJ, JeurninkSM, PeetersPH, BamiaC, ValanouE, TrichopoulouA, KaaksR, LukanovaA, BergmannMM, LindkvistB, StenlingR, JohanssonI, DahmCC, OvervadK, JensenM, OlsenA, TjonnelandA, LundE, RinaldiS, MichaudD, MouwT, RiboliE, and GonzalezCA. Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study. Int J Cancer, 131: E544–E554, 2012.
327.
SerenS, LiebermanR, BayraktarUD, HeathE, SahinK, AndicF, and KucukO. Lycopene in cancer prevention and treatment. Am J Ther, 15: 66–81, 2008.
328.
Sheikh-AliM, ChehadeJM, and MooradianAD. The antioxidant paradox in diabetes mellitus. Am J Ther, 18: 266–278, 2011.
329.
SimopoulosAP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med, 233: 674–688, 2008.
330.
SimopoulosAP. The traditional diet of Greece and cancer. Eur J Cancer Prev, 13: 219–230, 2004.
331.
SkrzydlewskaE, SulkowskiS, KodaM, ZalewskiB, Kanczuga-KodaL, and SulkowskaM. Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol, 11: 403–406, 2005.
332.
SkulachevVP, AntonenkoYN, CherepanovDA, ChernyakBV, IzyumovDS, KhailovaLS, KlishinSS, KorshunovaGA, LyamzaevKG, PletjushkinaOY, RoginskyVA, RokitskayaTI, SeverinFF, SeverinaII, SimonyanRA, SkulachevMV, SumbatyanNV, SukhanovaEI, TashlitskyVN, TrendelevaTA, VyssokikhMY, and ZvyagilskayaRA. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim Biophys Acta, 1797: 878–889, 2010.
333.
SmithRA and MurphyMP. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci, 1201: 96–103, 2010.
334.
SonodaY, WatanabeS, MatsumotoY, Aizu-YokotaE, and KasaharaT. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem, 274: 10566–10570, 1999.
335.
SoyalanB, MinnJ, SchmitzHJ, SchrenkD, WillF, DietrichH, BaumM, EisenbrandG, and JanzowskiC. Apple juice intervention modulates expression of ARE-dependent genes in rat colon and liver. Eur J Nutr, 50: 135–143, 2011.
336.
SpecialeA, ChirafisiJ, SaijaA, and CiminoF. Nutritional antioxidants and adaptive cell responses: an update. Curr Mol Med, 11: 770–789, 2011.
337.
SrikunD, AlbersAE, NamCI, IavaroneAT, and ChangCJ. Organelle-targetable fluorescent probes for imaging hydrogen peroxide in living cells via SNAP-Tag protein labeling. J Am Chem Soc, 132: 4455–4465, 2010.
338.
StadtmanER. Role of oxidant species in aging. Curr Med Chem, 11: 1105–1112, 2004.
339.
SuadicaniP, HeinHO, and GyntelbergF. Serum selenium level and risk of lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study. Eur Respir J, 39: 1443–1448, 2012.
340.
SugiyamaM, LinXH, and CostaM. Protective effect of vitamin E against chromosomal aberrations and mutation induced by sodium chromate in Chinese hamster V79 cells. Mutat Res, 260: 19–23, 1991.
341.
SupariF, UngererT, HarrisonDG, and WilliamsJK. Fish oil treatment decreases superoxide anions in the myocardium and coronary arteries of atherosclerotic monkeys. Circulation, 91: 1123–1128, 1995.
342.
SupinskiGS, MurphyMP, and CallahanLA. MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol, 297: R1095–R1102, 2009.
TachibanaH. Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci, 87: 66–80, 2011.
345.
TaguchiK, MotohashiH, and YamamotoM. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells, 16: 123–140, 2011.
346.
TakahashiA, OhtaniN, YamakoshiK, IidaS, TaharaH, NakayamaK, NakayamaKI, IdeT, SayaH, and HaraE. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol, 8: 1291–1297, 2006.
347.
TakeuchiH, FujimotoA, and HoonDS. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann N Y Acad Sci, 1022: 50–54, 2004.
348.
TamoriA, NishiguchiS, NishikawaM, KuboS, KohN, HirohashiK, ShiomiS, and InoueM. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma. J Gastroenterol, 39: 1063–1068, 2004.
349.
TanDJ, BaiRK, and WongLJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res, 62: 972–976, 2002.
350.
Teoh-FitzgeraldML, FitzgeraldMP, JensenTJ, FutscherBW, and DomannFE. Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis. Mol Cancer Res, 10: 40–51, 2012.
351.
TrachoothamD, AlexandreJ, and HuangP. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat Rev Drug Discov, 8: 579–591, 2009.
352.
TudekB, WinczuraA, JanikJ, SiomekA, FoksinskiM, and OlinskiR. Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am J Transl Res, 2: 254–284, 2010.
353.
TurkPW, LaayounA, SmithSS, and WeitzmanSA. DNA adduct 8-hydroxyl-2′-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis, 16: 1253–1255, 1995.
354.
TzonouA, LipworthL, GaridouA, SignorelloLB, LagiouP, HsiehC, and TrichopoulosD. Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer, 68: 300–304, 1996.
355.
UngvariZ, SonntagWE, de CaboR, BaurJA, and CsiszarA. Mitochondrial protection by resveratrol. Exerc Sport Sci Rev, 39: 128–132, 2011.
356.
UrsiniF, HeimS, KiessM, MaiorinoM, RoveriA, WissingJ, and FloheL. Dual function of the selenoprotein PHGPx during sperm maturation. Science, 285: 1393–1396, 1999.
357.
Ushio-FukaiM. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal, 11: 1289–1299, 2009.
358.
ValeroD, Diaz-MulaHM, ZapataPJ, CastilloS, GuillenF, Martinez-RomeroD, and SerranoM. Postharvest treatments with salicylic acid, acetylsalicylic acid or oxalic acid delayed ripening and enhanced bioactive compounds and antioxidant capacity in sweet cherry. J Agric Food Chem, 59: 5483–5489, 2011.
359.
ValkoM, RhodesCJ, MoncolJ, IzakovicM, and MazurM. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 160: 1–40, 2006.
360.
VallimT and SalterAM. Regulation of hepatic gene expression by saturated fatty acids. Prostaglandins Leukot Essent Fatty Acids, 82: 211–218, 2010.
361.
van den BrandtPA, GoldbohmRA, van ’t VeerP, BodeP, DorantE, HermusRJ, and SturmansF. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res, 53: 4860–4865, 1993.
362.
VargasAJ and BurdR. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutr Rev, 68: 418–428, 2010.
363.
VerhoyeE, LangloisMR, and Asklepios Investigators. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?. Clin Chem Lab Med, 47: 128–137, 2009.
364.
VieiraFG, Di PietroPF, BoaventuraBC, AmbrosiC, RockenbachG, FaustoMA, CrippaCG, and Da SilvaEL. Factors associated with oxidative stress in women with breast cancer. Nutr Hosp, 26: 528–536, 2011.
365.
VielEC, BenkiraneK, JaveshghaniD, TouyzRM, and SchiffrinEL. Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol, 295: H281–H288, 2008.
366.
VillamenaFA and ZweierJL. Detection of reactive oxygen and nitrogen species by EPR spin trapping. Antioxid Redox Signal, 6: 619–629, 2004.
367.
VinaJ, GambiniJ, Lopez-GruesoR, AbdelazizKM, JoveM, and BorrasC. Females live longer than males: role of oxidative stress. Curr Pharm Des, 17: 3959–3965, 2011.
368.
VirgiliF and MarinoM. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic Biol Med, 45: 1205–1216, 2008.
369.
VirtamoJ, PietinenP, HuttunenJK, KorhonenP, MalilaN, VirtanenMJ, AlbanesD, TaylorPR, AlbertP, and ATBC Study Group. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA, 290: 476–485, 2003.
370.
VisioliF, GrandeS, BoganiP, and GalliC. The role of antioxidants in the mediterranean diets: focus on cancer. Eur J Cancer Prev, 13: 337–343, 2004.
371.
VurusanerB, PoliG, and BasagaH. Tumor suppressor genes and ROS: complex networks of interactions. Free Radic Biol Med, 52: 7–18, 2012.
372.
WalsheJ, Serewko-AuretMM, TeakleN, CameronS, MintoK, SmithL, BurchamPC, RussellT, StruttonG, GriffinA, ChuFF, EsworthyS, ReeveV, and SaundersNA. Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res, 67: 4751–4758, 2007.
373.
WangFS, WangCJ, ChenYJ, ChangPR, HuangYT, SunYC, HuangHC, YangYJ, and YangKD. Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J Biol Chem, 279: 10331–10337, 2004.
374.
WangGL, JiangBH, and SemenzaGL. Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1. Biochem Biophys Res Commun, 212: 550–556, 1995.
375.
WangW, FangH, GroomL, ChengA, ZhangW, LiuJ, WangX, LiK, HanP, ZhengM, YinJ, WangW, MattsonMP, KaoJP, LakattaEG, SheuSS, OuyangK, ChenJ, DirksenRT, and ChengH. Superoxide flashes in single mitochondria. Cell, 134: 279–290, 2008.
376.
WeiWQ, AbnetCC, QiaoYL, DawseySM, DongZW, SunXD, FanJH, GunterEW, TaylorPR, and MarkSD. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr, 79: 80–85, 2004.
377.
WeinsteinSJ, PetersU, AhnJ, FriesenMD, RiboliE, HayesRB, and AlbanesD. Serum alpha-tocopherol and gamma-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study. PLoS One, 7: e40204, 2012.
378.
WillcoxDC, WillcoxBJ, TodorikiH, and SuzukiM. The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load. J Am Coll Nutr, 28 Suppl: 500S–516S, 2009.
379.
WinterbournCC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol, 4: 278–286, 2008.
380.
WinterbournCC and MetodiewaD. The reaction of superoxide with reduced glutathione. Arch Biochem Biophys, 314: 284–290, 1994.
381.
WisemanH and HalliwellB. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J, 313: 17–29, 1996.
382.
WooHA, YimSH, ShinDH, KangD, YuDY, and RheeSG. Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell, 140: 517–528, 2010.
383.
WoodPM. The potential diagram for oxygen at pH 7. Biochem J, 253: 287–289, 1988.
384.
WoodZA, PooleLB, and KarplusPA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science, 300: 650–653, 2003.
385.
WoodZA, SchroderE, Robin HarrisJ, and PooleLB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci, 28: 32–40, 2003.
386.
WuHC, WangQ, YangHI, AhsanH, TsaiWY, WangLY, ChenSY, ChenCJ, and SantellaRM. Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis, 29: 971–976, 2008.
387.
WuJ, SalisburyC, GrahamR, LyonsG, and FenechM. Increased consumption of wheat biofortified with selenium does not modify biomarkers of cancer risk, oxidative stress, or immune function in healthy Australian males. Environ Mol Mutagen, 50: 489–501, 2009.
388.
YangCS and WangH. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res, 55: 819–831, 2011.
389.
YaoH, AshiharaE, and MaekawaT. Targeting the Wnt/beta-catenin signaling pathway in human cancers. Expert Opin Ther Targets, 15: 873–887, 2011.
390.
YeonJY, SuhYJ, KimSW, BaikHW, SungCJ, KimHS, and SungMK. Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk. Nutrition, 27: 912–918, 2011.
391.
YokoeH, NomuraH, YamanoY, FushimiK, SakamotoY, OgawaraK, ShiibaM, BukawaH, UzawaK, TakiguchiY, and TanzawaH. Characterization of intracellular superoxide dismutase alterations in premalignant and malignant lesions of the oral cavity: correlation with lymph node metastasis. J Cancer Res Clin Oncol, 135: 1625–1633, 2009.
392.
YooHY, ChangMS, and RhoHM. Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene, 234: 87–91, 1999.
393.
Yue QianS, KadiiskaMB, GuoQ, and MasonRP. A novel protocol to identify and quantify all spin trapped free radicals from in vitro/in vivo interaction of HO(.-) and DMSO: LC/ESR, LC/MS, and dual spin trapping combinations. Free Radic Biol Med, 38: 125–135, 2005.
394.
ZhangCX, HoSC, ChenYM, FuJH, ChengSZ, and LinFY. Greater vegetable and fruit intake is associated with a lower risk of breast cancer among Chinese women. Int J Cancer, 125: 181–188, 2009.
395.
ZhangW, ShuXO, LiH, YangG, CaiH, JiBT, GaoJ, GaoYT, ZhengW, and XiangYB. Vitamin intake and liver cancer risk: a report from two cohort studies in China. J Natl Cancer Inst, 104: 1173–1181, 2012.
396.
ZhangZF, KurtzRC, YuGP, SunM, GargonN, KarpehMJr., FeinJS, and HarlapS. Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer, 27: 298–309, 1997.
397.
ZhaoCR, GaoZH, and QuXJ. Nrf2-ARE signaling pathway and natural products for cancer chemoprevention. Cancer Epidemiol, 34: 523–533, 2010.
398.
ZiechD, FrancoR, PappaA, and PanayiotidisMI. Reactive oxygen species (ROS)—induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res, 711: 167–173, 2011.
399.
ZielonkaJ and KalyanaramanB. Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med, 48: 983–1001, 2010.
400.
ZuoXL, ChenJM, ZhouX, LiXZ, and MeiGY. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res, 114: 41–53, 2006.
